Denovicon Therapeutics

Denovicon Therapeutics aims to accelerate and improve the development of small-molecule therapies by leveraging decades of valuable drug discovery expertise, a proven computational platform, advanced hardware infrastructure, and proprietary AI molecular modeling (hybrid) algorithms. Currently focused on small-molecule therapies targeting oncology and immuno-oncology.